{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/215258878"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Chad's FDA matters involve petitioning FDA and litigating issues relating to the Hatch-Waxman Act, including marketing exclusivities, patent listing, certification and notification requirements, bioequivalence, labeling and other issues relevant to the FDA drug approval process." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "axinn.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/141884859"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/215258878" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/360452896"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/215258878"] } } }
